This may show up in individuals with higher underlying oxidative stress, such as newborns, people with sickle cell disease, and those using oxidative drugs, as well as lower post-transfusion reactivity of stored G6PD-deficient RBCs and decreased transfusion efficacy in patients. The gene discussed is G6PD; the disease is sickle cell disease.